{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:36:44Z","timestamp":1792165004544,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T00:00:00Z","timestamp":1350691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1746-1596-7-145","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T18:14:01Z","timestamp":1350756841000},"source":"Crossref","is-referenced-by-count":30,"title":["A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas"],"prefix":"10.1186","volume":"7","author":[{"given":"Asli","family":"Cakir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek Isik","family":"Gonul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Uluoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,20]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 2010. CA Cancer J Clin. 2010, 60: 277-300. 10.3322\/caac.20073.","journal-title":"CA Cancer J Clin"},{"key":"618_CR2","first-page":"13","volume-title":"Pathology and Genetics of Tumours of the Breast and Female Genital Organs","author":"World Health Organization Classification of Tumours","year":"2003","unstructured":"World Health Organization Classification of Tumours: Invasive breast carcinoma. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Edited by: Tavassoli FA, Devilee P. 2003, Lyon: IARC Press, 13-59."},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ: Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011, 22: 1736-1747. 10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al.: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038\/35021093.","journal-title":"Nature"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al.: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003, 100: 8418-8423. 10.1073\/pnas.0932692100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/modpathol.3800570","volume":"19","author":"BB Bryan","year":"2006","unstructured":"Bryan BB, Schnitt SJ, Collins LC: Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006, 19: 617-621. 10.1038\/modpathol.3800570.","journal-title":"Mod Pathol"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, et al.: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006, 295: 2492-2502. 10.1001\/jama.295.21.2492.","journal-title":"JAMA"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/PAP.0b013e31814b26fe","volume":"14","author":"O Fadare","year":"2007","unstructured":"Fadare O, Tavassoli FA: The phenotypic spectrum of basal-like breast cancers: a critical appraisal. Adv Anat Pathol. 2007, 14: 358-373. 10.1097\/PAP.0b013e31814b26fe.","journal-title":"Adv Anat Pathol"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2559.2006.02453.x","volume":"49","author":"LG Fulford","year":"2006","unstructured":"Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A: Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology. 2006, 49: 22-34. 10.1111\/j.1365-2559.2006.02453.x.","journal-title":"Histopathology"},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/modpathol.3800528","volume":"19","author":"CA Livasy","year":"2006","unstructured":"Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM: Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006, 19: 264-271. 10.1038\/modpathol.3800528.","journal-title":"Mod Pathol"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, et al.: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004, 10: 5367-5374. 10.1158\/1078-0432.CCR-04-0220.","journal-title":"Clin Cancer Res"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/jcp.2008.061358","volume":"62","author":"S Pintens","year":"2009","unstructured":"Pintens S, Neven P, Drijkoningen M, Van Belle V, Moerman P, Christiaens MR, Smeets A, Wildiers H, Vanden Bempt I: Triple negative breast cancer: a study from the point of view of basal CK5\/6 and HER-1. J Clin Pathol. 2009, 62: 624-628. 10.1136\/jcp.2008.061358.","journal-title":"J Clin Pathol"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00428-005-0010-7","volume":"447","author":"I Matos","year":"2005","unstructured":"Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F: p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005, 447: 688-694. 10.1007\/s00428-005-0010-7.","journal-title":"Virchows Arch"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","volume":"52","author":"JS Reis-Filho","year":"2008","unstructured":"Reis-Filho JS, Tutt AN: Triple negative tumours: a critical review. Histopathology. 2008, 52: 108-118.","journal-title":"Histopathology"},{"key":"618_CR15","first-page":"600","volume":"3","author":"OL Bohn","year":"2010","unstructured":"Bohn OL, Fuertes-Camilo M, Navarro L, Saldivar J, Sanchez-Sosa S: p16INK4a expression in basal-like breast carcinoma. Int J Clin Exp Pathol. 2010, 3: 600-607.","journal-title":"Int J Clin Exp Pathol"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"618_CR17","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/jnci\/djg050","volume":"95","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, Trudel M, Akslen LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003, 95: 1482-1485. 10.1093\/jnci\/djg050.","journal-title":"J Natl Cancer Inst"},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.humpath.2006.11.015","volume":"38","author":"S Garcia","year":"2007","unstructured":"Garcia S, Dales JP, Charafe-Jauffret E, Carpentier-Meunier S, Andrac-Meyer L, Jacquemier J, Andonian C, Lavaut MN, Allasia C, Bonnier P, Charpin C: Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum Pathol. 2007, 38: 830-841. 10.1016\/j.humpath.2006.11.015.","journal-title":"Hum Pathol"},{"key":"618_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991, 19: 403-410. 10.1111\/j.1365-2559.1991.tb00229.x.","journal-title":"Histopathology"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1524-4741.2008.00682.x","volume":"15","author":"E Ayad","year":"2009","unstructured":"Ayad E, Francis I, Peston D, Shousha S: Triple negative, basal cell type and EGFR positive invasive breast carcinoma in Kuwaiti and British patients. Breast J. 2009, 15: 109-111. 10.1111\/j.1524-4741.2008.00682.x.","journal-title":"Breast J"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, et al.: American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007, 25: 118-145.","journal-title":"J Clin Oncol"},{"key":"618_CR22","first-page":"774","volume":"15","author":"H Demir","year":"2010","unstructured":"Demir H, Turna H, Can G, Ilvan S: Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression. J BUON. 2010, 15: 774-782.","journal-title":"J BUON"},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/PAI.0b013e3181630e98","volume":"16","author":"M Chivukula","year":"2008","unstructured":"Chivukula M, Striebel JM, Ersahin C, Dabbs DJ: Evaluation of morphologic features to identify \u201cbasal-like phenotype\u201d on core needle biopsies of breast. Appl Immunohistochem Mol Morphol. 2008, 16: 411-416. 10.1097\/PAI.0b013e3181630e98.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/j.1600-0463.2007.00862.x","volume":"115","author":"H Nalwoga","year":"2007","unstructured":"Nalwoga H, Arnes JB, Wabinga H, Akslen LA: Frequency of the basal-like phenotype in African breast cancer. APMIS. 2007, 115: 1391-1399. 10.1111\/j.1600-0463.2007.00862.x.","journal-title":"APMIS"},{"issue":"Suppl 2","key":"618_CR25","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.breast.2007.07.017","volume":"16","author":"J Kurebayashi","year":"2007","unstructured":"Kurebayashi J, Moriya T, Ishida T, Hirakawa H, Kurosumi M, Akiyama F, Kinoshita T, Takei H, Takahashi K, Ikeda M, Nakashima K: The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast. 2007, 16 (Suppl 2): S72-77.","journal-title":"Breast"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-011-1709-6","volume":"130","author":"Y Wang","year":"2011","unstructured":"Wang Y, Yin Q, Yu Q, Zhang J, Liu Z, Wang S, Lv S, Niu Y: A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments. Breast Cancer Res Treat. 2011, 130: 489-498. 10.1007\/s10549-011-1709-6.","journal-title":"Breast Cancer Res Treat"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.humpath.2006.04.015","volume":"37","author":"MJ Kim","year":"2006","unstructured":"Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G: Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2\/neu-overexpressing phenotypes. Hum Pathol. 2006, 37: 1217-1226. 10.1016\/j.humpath.2006.04.015.","journal-title":"Hum Pathol"},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/path.1916","volume":"208","author":"EA Rakha","year":"2006","unstructured":"Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO: Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol. 2006, 208: 495-506. 10.1002\/path.1916.","journal-title":"J Pathol"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.2407","volume":"216","author":"B Weigelt","year":"2008","unstructured":"Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, de Jong D, Van de Vijver MJ, Van\u2019t Veer LJ, Peterse JL: Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008, 216: 141-150. 10.1002\/path.2407.","journal-title":"J Pathol"},{"key":"618_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.humpath.2007.07.014","volume":"39","author":"O Fadare","year":"2008","unstructured":"Fadare O, Wang SA, Hileeto D: The expression of cytokeratin 5\/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?. Hum Pathol. 2008, 39: 331-336. 10.1016\/j.humpath.2007.07.014.","journal-title":"Hum Pathol"},{"key":"618_CR31","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/modpathol.3800483","volume":"18","author":"S Azoulay","year":"2005","unstructured":"Azoulay S, Lae M, Freneaux P, Merle S, Al Ghuzlan A, Chnecker C, Rosty C, Klijanienko J, Sigal-Zafrani B, Salmon R, et al.: KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol. 2005, 18: 1623-1631.","journal-title":"Mod Pathol"},{"key":"618_CR32","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1158\/0008-5472.CAN-06-0031","volume":"66","author":"F Bertucci","year":"2006","unstructured":"Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adelaide J, Debono S, Houvenaeghel G, Maraninchi D, Viens P, et al.: Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006, 66: 4636-4644. 10.1158\/0008-5472.CAN-06-0031.","journal-title":"Cancer Res"},{"key":"618_CR33","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/modpathol.2010.123","volume":"23","author":"F Marginean","year":"2010","unstructured":"Marginean F, Rakha EA, Ho BC, Ellis IO, Lee AH: Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Mod Pathol. 2010, 23: 1357-1363. 10.1038\/modpathol.2010.123.","journal-title":"Mod Pathol"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/path.1845","volume":"207","author":"J Jacquemier","year":"2005","unstructured":"Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, Fiche M, Figueiro P, Maisongrosse V, Ledoussal V, et al.: Typical medullary breast carcinomas have a basal\/myoepithelial phenotype. J Pathol. 2005, 207: 260-268. 10.1002\/path.1845.","journal-title":"J Pathol"},{"key":"618_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10549-008-0197-9","volume":"117","author":"B Weigelt","year":"2009","unstructured":"Weigelt B, Kreike B, Reis-Filho JS: Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat. 2009, 117: 273-280. 10.1007\/s10549-008-0197-9.","journal-title":"Breast Cancer Res Treat"},{"key":"618_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2559.2006.02467.x","volume":"49","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC: Metaplastic breast carcinomas are basal-like tumours. Histopathology. 2006, 49: 10-21. 10.1111\/j.1365-2559.2006.02467.x.","journal-title":"Histopathology"},{"key":"618_CR37","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/bcr1517","volume":"8","author":"S Calza","year":"2006","unstructured":"Calza S, Hall P, Auer G, Bjohle J, Klaar S, Kronenwett U, Liu ET, Miller L, Ploner A, Smeds J, et al.: Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 2006, 8: R34-10.1186\/bcr1517.","journal-title":"Breast Cancer Res"},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1245\/s10434-009-0606-2","volume":"16","author":"L Wiechmann","year":"2009","unstructured":"Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M: Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol. 2009, 16: 2705-2710. 10.1245\/s10434-009-0606-2.","journal-title":"Ann Surg Oncol"},{"key":"618_CR39","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-05-2281","volume":"12","author":"SM Rodriguez-Pinilla","year":"2006","unstructured":"Rodriguez-Pinilla SM, Sarrio D, Honrado E, Hardisson D, Calero F, Benitez J, Palacios J: Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res. 2006, 12: 1533-1539. 10.1158\/1078-0432.CCR-05-2281.","journal-title":"Clin Cancer Res"},{"key":"618_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3816\/CBC.2008.n.028","volume":"8","author":"SJ Crabb","year":"2008","unstructured":"Crabb SJ, Cheang MC, Leung S, Immonen T, Nielsen TO, Huntsman DD, Bajdik CD, Chia SK: Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer. 2008, 8: 249-256. 10.3816\/CBC.2008.n.028.","journal-title":"Clin Breast Cancer"},{"key":"618_CR41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.prp.2010.07.012","volume":"206","author":"S Ben Abdelkrim","year":"2010","unstructured":"Ben Abdelkrim S, Trabelsi A, Missaoui N, Beizig N, Bdioui A, Anjorin A, Jomaa W, Mokni M: Distribution of molecular breast cancer subtypes among Tunisian women and correlation with histopathological parameters: a study of 194 patients. Pathol Res Pract. 2010, 206: 772-775. 10.1016\/j.prp.2010.07.012.","journal-title":"Pathol Res Pract"},{"key":"618_CR42","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1158\/0008-5472.CAN-03-2970","volume":"64","author":"WD Foulkes","year":"2004","unstructured":"Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Begin LR, Hamel N, Goffin JR, Wong N, Trudel M, et al.: The prognostic implication of the basal-like (cyclin E high\/p27 low\/p53+\/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res. 2004, 64: 830-835. 10.1158\/0008-5472.CAN-03-2970.","journal-title":"Cancer Res"},{"key":"618_CR43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5858\/133.6.860","volume":"133","author":"E Rakha","year":"2009","unstructured":"Rakha E, Reis-Filho JS: Basal-like breast carcinoma: from expression profiling to routine practice. Arch Pathol Lab Med. 2009, 133: 860-868.","journal-title":"Arch Pathol Lab Med"},{"key":"618_CR44","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/01.pas.0000213306.05811.b9","volume":"30","author":"DG Hicks","year":"2006","unstructured":"Hicks DG, Short SM, Prescott NL, Tarr SM, Coleman KA, Yoder BJ, Crowe JP, Choueiri TK, Dawson AE, Budd GT, et al.: Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR. Am J Surg Pathol. 2006, 30: 1097-1104.","journal-title":"Am J Surg Pathol"},{"key":"618_CR45","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/jcp.2005.033043","volume":"59","author":"S Banerjee","year":"2006","unstructured":"Banerjee S, Reis-Filho JS, Ashley S, Steele D, Ashworth A, Lakhani SR, Smith IE: Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol. 2006, 59: 729-735. 10.1136\/jcp.2005.033043.","journal-title":"J Clin Pathol"},{"key":"618_CR46","doi-asserted-by":"publisher","first-page":"7497","DOI":"10.1200\/JCO.2005.02.1147","volume":"23","author":"NJ Coombs","year":"2005","unstructured":"Coombs NJ, Boyages J: Multifocal and multicentric breast cancer: does each focus matter?. J Clin Oncol. 2005, 23: 7497-7502. 10.1200\/JCO.2005.02.1147.","journal-title":"J Clin Oncol"},{"key":"618_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cancergencyto.2010.09.012","volume":"204","author":"HG Russnes","year":"2011","unstructured":"Russnes HG, Kuligina E, Suspitsin EN, Voskresenskiy DA, Jordanova ES, Cornelisse CJ, Borresen-Dale AL, Imyanitov EN: Paired distribution of molecular subtypes in bilateral breast carcinomas. Cancer Genet. 2011, 204: 96-102. 10.1016\/j.cancergencyto.2010.09.012.","journal-title":"Cancer Genet"},{"key":"618_CR48","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1245\/s10434-010-1480-7","volume":"18","author":"T Tot","year":"2011","unstructured":"Tot T, Pekar G: Multifocality in \u201cbasal-like\u201d breast carcinomas and its influence on lymph node status. Ann Surg Oncol. 2011, 18: 1671-1677. 10.1245\/s10434-010-1480-7.","journal-title":"Ann Surg Oncol"},{"key":"618_CR49","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/PAS.0b013e3181e02f45","volume":"34","author":"AA Thike","year":"2010","unstructured":"Thike AA, Iqbal J, Cheok PY, Chong AP, Tse GM, Tan B, Tan P, Wong NS, Tan PH: Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surg Pathol. 2010, 34: 956-964. 10.1097\/PAS.0b013e3181e02f45.","journal-title":"Am J Surg Pathol"},{"key":"618_CR50","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.humpath.2010.08.024","volume":"42","author":"D Martins","year":"2011","unstructured":"Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, Paredes J, Schmitt F: Molecular phenotypes of matched in situ and invasive components of breast carcinomas. Hum Pathol. 2011, 42: 1438-1446. 10.1016\/j.humpath.2010.08.024.","journal-title":"Hum Pathol"},{"key":"618_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00795-010-0504-5","volume":"43","author":"T Moriya","year":"2010","unstructured":"Moriya T, Kanomata N, Kozuka Y, Hirakawa H, Kimijima I, Kimura M, Watanabe M, Sasano H, Ishida T, Ohuchi N, et al.: Molecular morphological approach to the pathological study of development and advancement of human breast cancer. Med Mol Morphol. 2010, 43: 67-73. 10.1007\/s00795-010-0504-5.","journal-title":"Med Mol Morphol"},{"key":"618_CR52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ijc.23518","volume":"123","author":"F Bertucci","year":"2008","unstructured":"Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, Birnbaum D: How basal are triple-negative breast cancers?. Int J Cancer. 2008, 123: 236-240. 10.1002\/ijc.23518.","journal-title":"Int J Cancer"},{"key":"618_CR53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/jcp.2008.055475","volume":"61","author":"E Korsching","year":"2008","unstructured":"Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H: Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol. 2008, 61: 553-560. 10.1136\/jcp.2008.055475.","journal-title":"J Clin Pathol"},{"key":"618_CR54","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/bcr1771","volume":"9","author":"B Kreike","year":"2007","unstructured":"Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ: Gene expression profiling and histopathological characterization of triple-negative\/basal-like breast carcinomas. Breast Cancer Res. 2007, 9: R65-10.1186\/bcr1771.","journal-title":"Breast Cancer Res"},{"key":"618_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1746-1596-7-73","volume":"7","author":"M Noriega","year":"2012","unstructured":"Noriega M, Paesani F, Perazzo F, Lago N, Krupitzki H, Nieto S, Garcia A, Avagnina A, Elsner B, Denninghoff VC: Immunohistochemical characterization of neoplastic cells of breast origin. Diagn Pathol. 2012, 7: 73-","journal-title":"Diagn Pathol"},{"key":"618_CR56","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1200\/JCO.2007.13.1748","volume":"26","author":"EA Rakha","year":"2008","unstructured":"Rakha EA, Reis-Filho JS, Ellis IO: Basal-like breast cancer: a critical review. J Clin Oncol. 2008, 26: 2568-2581. 10.1200\/JCO.2007.13.1748.","journal-title":"J Clin Oncol"},{"key":"618_CR57","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0002-9440(10)64476-8","volume":"161","author":"M van de Rijn","year":"2002","unstructured":"van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Kochli OR, et al.: Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002, 161: 1991-1996. 10.1016\/S0002-9440(10)64476-8.","journal-title":"Am J Pathol"},{"key":"618_CR58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/path.1559","volume":"203","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO: Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004, 203: 661-671. 10.1002\/path.1559.","journal-title":"J Pathol"},{"key":"618_CR59","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/bcr1636","volume":"9","author":"LG Fulford","year":"2007","unstructured":"Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A, Easton D, Lakhani SR: Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res. 2007, 9: R4-10.1186\/bcr1636.","journal-title":"Breast Cancer Res"},{"key":"618_CR60","first-page":"249","volume":"25","author":"D Birnbaum","year":"2004","unstructured":"Birnbaum D, Bertucci F, Ginestier C, Tagett R, Jacquemier J, Charafe-Jauffret E: Basal and luminal breast cancers: basic or luminous? (review). Int J Oncol. 2004, 25: 249-258.","journal-title":"Int J Oncol"},{"key":"618_CR61","first-page":"2958","volume":"7","author":"F Ciardiello","year":"2001","unstructured":"Ciardiello F, Tortora G: A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res. 2001, 7: 2958-2970.","journal-title":"Clin Cancer Res"},{"key":"618_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1440-1827.2007.02183.x","volume":"58","author":"EY Cho","year":"2008","unstructured":"Cho EY, Choi YL, Han JJ, Kim KM, Oh YL: Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathol Int. 2008, 58: 17-25.","journal-title":"Pathol Int"},{"key":"618_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO: Prognostic markers in triple-negative breast cancer. Cancer. 2007, 109: 25-32. 10.1002\/cncr.22381.","journal-title":"Cancer"},{"key":"618_CR64","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1746-1596-6-118","volume":"6","author":"N Lv","year":"2011","unstructured":"Lv N, Xie X, Ge Q, Lin S, Wang X, Kong Y, Shi H, Wei W: Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations. Diagn Pathol. 2011, 6: 118-10.1186\/1746-1596-6-118.","journal-title":"Diagn Pathol"},{"key":"618_CR65","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2559.2011.03921.x","volume":"59","author":"MM Shao","year":"2011","unstructured":"Shao MM, Zhang F, Meng G, Wang XX, Xu H, Yu XW, Chen LY, Tse GM: Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast. Histopathology. 2011, 59: 264-273.","journal-title":"Histopathology"},{"key":"618_CR66","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/bjc.1988.81","volume":"57","author":"G Cattoretti","year":"1988","unstructured":"Cattoretti G, Andreola S, Clemente C, D\u2019Amato L, Rilke F: Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer. 1988, 57: 353-357. 10.1038\/bjc.1988.81.","journal-title":"Br J Cancer"},{"key":"618_CR67","first-page":"1299","volume":"137","author":"W Domagala","year":"1990","unstructured":"Domagala W, Lasota J, Dukowicz A, Markiewski M, Striker G, Weber K, Osborn M: Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol. 1990, 137: 1299-1304.","journal-title":"Am J Pathol"},{"key":"618_CR68","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1158\/1078-0432.CCR-06-0353","volume":"12","author":"M Laakso","year":"2006","unstructured":"Laakso M, Tanner M, Nilsson J, Wiklund T, Erikstein B, Kellokumpu-Lehtinen P, Malmstrom P, Wilking N, Bergh J, Isola J: Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer. Clin Cancer Res. 2006, 12: 4185-4191. 10.1158\/1078-0432.CCR-06-0353.","journal-title":"Clin Cancer Res"},{"key":"618_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1746-1596-7-27","volume":"7","author":"A Laurinavicius","year":"2012","unstructured":"Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J: Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol. 2012, 7: 27-10.1186\/1746-1596-7-27.","journal-title":"Diagn Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-1596-7-145\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T11:47:06Z","timestamp":1643543226000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-7-145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,20]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-7-145","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,20]]},"article-number":"145"}}